Gartner, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount
Gartner, Inc. (IT) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount of -$161.90 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization · last filed 2026-02-12
- Gartner, Inc. effective income tax rate reconciliation, nondeductible expense, amortization, amount for the quarter ending 2019-12-31 was $76.20M.
- Gartner, Inc. effective income tax rate reconciliation, nondeductible expense, amortization, amount for the quarter ending 2019-09-30 was $0.00.
- Gartner, Inc. effective income tax rate reconciliation, nondeductible expense, amortization, amount for the quarter ending 2019-06-30 was -$38.10M.
- Gartner, Inc. effective income tax rate reconciliation, nondeductible expense, amortization, amount for fiscal 2024 was -$161.90M.
- Gartner, Inc. effective income tax rate reconciliation, nondeductible expense, amortization, amount for fiscal 2021 was $54.10M, a 91.17% increase from fiscal 2020.
- Gartner, Inc. effective income tax rate reconciliation, nondeductible expense, amortization, amount for fiscal 2020 was $28.30M, a 25.72% decline from fiscal 2019.
- Gartner, Inc. effective income tax rate reconciliation, nondeductible expense, amortization, amount for fiscal 2019 was $38.10M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount 6 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount 9 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$161.90M 10-K · filed 2026-02-12 | |||
| 2021-12-31 | $54.10M 10-K · filed 2023-02-16 | |||
| 2020-12-31 | $28.30M 10-K · filed 2023-02-16 | |||
| 2019-12-31 | $76.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $76.20M derived: sum of 2 quarters · filed 2022-02-23 | $38.10M derived: sum of 3 quarters · filed 2022-02-23 | $38.10M 10-K · filed 2022-02-23 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$38.10M derived: sum of 2 quarters · filed 2019-10-31 | -$38.10M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | -$38.10M 10-Q · filed 2019-07-30 | -$38.10M 10-Q · filed 2019-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |